Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

Published on 21 Mar 2024 on GuruFocus.com via Yahoo Finance

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercialization of cancer immunotherapies, has reported an insider sell according to a recent SEC filing. Chief Operating Officer Jennifer Jarrett sold 13,449 shares of the company on March 18, 2024. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this SEC Filing link.

Warning! GuruFocus has detected 4 Warning Signs with RCUS.

Read the rest of the article

NYSE.RCUS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

The market expects Arcus Biosciences, Inc. (RCUS) to deliver a year-over-year increase in earning...

Zacks via Yahoo Finance 1 May 2024

Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercia...

GuruFocus.com via Yahoo Finance 29 Mar 2024

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercia...

GuruFocus.com via Yahoo Finance 21 Mar 2024

Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (NYSE:RCUS), a company focused on creating and developing cancer immunother...

GuruFocus.com via Yahoo Finance 29 Feb 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript

Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript February 22, 2024 Arcus Bios...

Insider Monkey via Yahoo Finance 22 Feb 2024

Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before...

Arcus Biosciences, Inc. (RCUS) closed the last trading session at $16.41, gaining 7.6% over the p...

Zacks via Yahoo Finance 22 Feb 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Just Trimmed Their Revenue Forecasts By 17%

One thing we could say about the analysts on Arcus Biosciences, Inc. (NYSE:RCUS) - they aren't op...

Simply Wall St. via Yahoo Finance 12 Nov 2023

Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript

Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: T...

Insider Monkey via Yahoo Finance 8 Nov 2023

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Wall Street expects a year-over-year decline in earnings on lower revenues when Arcus Biosciences...

Zacks via Yahoo Finance 1 Nov 2023

Arcus Biosciences' (NYSE:RCUS) investors will be pleased with their notable 66% return over the last...

Arcus Biosciences, Inc. (NYSE:RCUS) shareholders might be concerned after seeing the share price ...

Simply Wall St. via Yahoo Finance 23 Oct 2023

News

Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)

NYSE.RCUS price evolution

Want to become a better investor?